Silence Therapeutics PLC Holding(s) in Company (6285Q)
October 28 2021 - 11:02AM
UK Regulatory
TIDMSLN
RNS Number : 6285Q
Silence Therapeutics PLC
28 October 2021
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft
Word format if possible) i
1a. Identity of the issuer or the underlying issuer Silence Therapeutics plc
of existing shares to which voting rights are
attached ii :
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
------------
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights x
------------
An acquisition or disposal of financial instruments
------------
An event changing the breakdown of voting rights
------------
Other (please specify) iii :
------------
3. Details of person subject to the notification obligation iv
Name LOIM Lombard Odier Asset Management (Europe) Limited
-------------------------------------------------------------------------------
City and country of registered London, United Kingdom
office (if applicable)
-------------------------------------------------------------------------------
4. Full name of shareholder(s) (if different from 3.) v
Name
-------------------------------------------------------------------------------
City and country of registered
office (if applicable)
-------------------------------------------------------------------------------
5. Date on which the threshold was 25/10/2021
crossed or reached vi :
6. Date on which issuer notified 26/10/2021
(DD/MM/YYYY):
-------------------------------------------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights through Total of both in Total number of voting rights
rights attached financial instruments (total % (8.A + 8.B) of issuer vii
to shares (total of 8.B 1 + 8.B 2)
of 8. A)
----------------- ------------------------------ ---------------- -----------------------------
Resulting
situation on
the date on
which threshold
was crossed or
reached 8.84% 2.17% 11.01% 89,777,000
----------------- ------------------------------ ---------------- -----------------------------
Position of
previous
notification
(if applicable) 5.94% 4.20% 10.14%
----------------- ------------------------------ ---------------- -----------------------------
ISIN CODE (if possible)
GB00B9GTXM62 Ordinary
SUBTOTAL 8. A
8. Notified details of the resulting situation on the date on which the threshold was crossed
or reached viii
A: Voting rights attached to shares
Class/type of Number of voting rights ix % of voting rights
shares
ISIN CODE (if possible)
Direct (Art 9 of Indirect (Art 10 of Direct (Art 9 of Indirect (Art 10 of
Directive Directive Directive 2004/109/EC) Directive
2004/109/EC) (DTR5.1) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.2.1) (DTR5.2.1)
GB00B9GTXM62 Ordinary 7,935,940 8.84%
--------------------- --------------------- ---------------------- ---------------------
SUBTOTAL 8. A 7,935,940 8.84%
-------------------------------------------- ---------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1
(a))
Number of voting rights % of voting rights
Type of financial Expiration Exercise/ that may be acquired if
instrument date x Conversion Period xi the instrument is
exercised/converted.
ADR US82686Q1013 1,951,032 2.17%
------------------
SUBTOTAL 8. B 1 1,951,032 2.17%
----------------------- ------------------------ ------------------
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive
2004/109/EC (DTR5.3.1.1 (b))
Type of financial Expiration date x Exercise/ Physical or cash Number of voting % of voting rights
instrument Conversion Period settlement xii rights
xi
CASH
----------------- ------------------ ----------------- ------------------ ------------------
SUBTOTAL 8.B.2
----------------- ------------------ ------------------
9. Information in relation to the person subject to the notification obligation (please mark
the
applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal x
entity and does not control any other undertaking(s) holding directly or indirectly an interest
in the (underlying) issuer xiii
------------
Full chain of controlled undertakings through which the voting rights and/or the financial
instruments are effectively held starting with the ultimate controlling natural person or
legal entity xiv (please add additional rows as necessary)
------------
Name xv % of voting rights if it % of voting rights Total of both if it equals or is higher
equals or is higher than through financial than the notifiable threshold
the notifiable threshold instruments if it equals
or is higher than the
notifiable
threshold
------------------------- ------------------------ ---------------------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information xvi
Place of completion London
Date of completion 26/10/2021
----------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLUWRVRARURUAA
(END) Dow Jones Newswires
October 28, 2021 11:02 ET (15:02 GMT)
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Oct 2024 to Nov 2024
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Nov 2023 to Nov 2024
